CXCL12 and hepatocellular carcinoma: Indeed, CXCR4 and its ligand CXCL12 initiate cell migration and angiogenesis via activation of the MAPK/ERK and PI3K/Akt signaling pathways, thereby promoting HCC cells growth, proliferation, metastasis and invasion (Yang et al., 2019).